119 related articles for article (PubMed ID: 6543290)
1. [Detection of circulating immune complexes by polyethyleneglycol precipitations complement consumption test in urological malignant diseases].
Sakai S; Kato N; Ito Y; Matsuda S; Koide T; Deguti T; Kuriyama M; Ban Y; Nishiura T; Tei K
Hinyokika Kiyo; 1984 Nov; 30(11):1611-7. PubMed ID: 6543290
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum prostate-specific antigen in urologic cancers.
Takeuchi T; Kuriyama M; Fujihiro S; Fujimoto Y; Okano M; Nishiura T
J Surg Oncol; 1983 Oct; 24(2):157-60. PubMed ID: 6195484
[TBL] [Abstract][Full Text] [Related]
4. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
[No Abstract] [Full Text] [Related]
5. [Urine polyamine in patients with malignant urological diseases using a polyamine-test enzyme kit].
Sakai S; Koide T; Ito Y; Tei K; Deguchi T; Matsuda S; Kato N; Ban Y; Nishiura T
Hinyokika Kiyo; 1986 May; 32(5):661-5. PubMed ID: 3751793
[TBL] [Abstract][Full Text] [Related]
6. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Kazama T; Katayama T; Yamazaki N
Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of circulating immune complexes in cancer patients.
Dass TK; Aziz M; Rattan A
Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
[TBL] [Abstract][Full Text] [Related]
8. Effect of surgical stress on immune function in patients with urologic cancer.
Mizutani Y; Terachi T; Okada Y; Yoshida O
Int J Urol; 1996 Nov; 3(6):426-34. PubMed ID: 9170568
[TBL] [Abstract][Full Text] [Related]
9. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
[No Abstract] [Full Text] [Related]
10. Interleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological cancer.
Kuo JY; Ohmoto Y; Yoshida O
Hinyokika Kiyo; 1998 Jun; 44(6):397-402. PubMed ID: 9719938
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of circulating immune complexes by polyethylene glycol precipitation-complement consumption test (PEG-cc test) and PEG precipitation method using radial immunodiffusion. Clinical application to glomerulonephritis].
Takada K; Arakawa M; Seino J; Furuyama T; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1983 Mar; 25(3):257-69. PubMed ID: 6411953
[No Abstract] [Full Text] [Related]
12. [Immune parameters of peripheral blood in chemoembolization with microencapsulated anticancer drugs].
Sato K; Abe R; Moriyama M; Kato T; Tsuchida S
Gan To Kagaku Ryoho; 1989 Jan; 16(1):73-7. PubMed ID: 2783546
[TBL] [Abstract][Full Text] [Related]
13. p53 autoantibodies in patients with urological tumours.
Lang C; Unteregger G; Kartarius S; Günther J; Bonkhoff H; Montenarh M; Zwergel T
Br J Urol; 1998 Nov; 82(5):721-6. PubMed ID: 9839589
[TBL] [Abstract][Full Text] [Related]
14. [Study on circulating immune complexes in collagen diseases by the polyethylene glycol precipitation method and the polyethylene glycol precipitation-complement consumption test (author's transl)].
Ezaki I; Sakai K; Nobunaga M
Ryumachi; 1981 Sep; 21(5):375-84. PubMed ID: 7330732
[No Abstract] [Full Text] [Related]
15. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.
Kaver I; Pecht M; Trainin N; Greenstein A; Braf Z
Oncology; 1992; 49(2):108-13. PubMed ID: 1574245
[TBL] [Abstract][Full Text] [Related]
16. Serial measurement of circulating immune complexes in healthy subjects.
Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD44 variants in the serum of patients with urological malignancies.
Lein M; Jung K; Weiss S; Schnorr D; Loening SA
Oncology; 1997; 54(3):226-30. PubMed ID: 9143404
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in patients with advanced pulmonary tuberculosis detected by a polyethylene glycol precipitation-complement consuming test (PEG-CC test).
Rojas-Espinosa O; Oltra A; Arce P
Rev Latinoam Microbiol; 1988; 30(1):25-9. PubMed ID: 3140341
[No Abstract] [Full Text] [Related]
19. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).
Harkiss GD; Brown DL
Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880
[TBL] [Abstract][Full Text] [Related]
20. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
